At the recent 17th International Myeloma Workshop  hosted by International Myeloma Society (IMS), Professor Andrew Spencer represented AMaRC in showcasing Investigator-Initiated Trials in Australia for Multiple Myeloma patients to over 3200 registered delegates from around the world. 

Credit: Photo from A/Prof Hang Quach's Twitter feed.